ORGANIC
LETTERS
2011
Vol. 13, No. 22
6038–6041
A Kiyooka Aldol Approach for the
Synthesis of the C(14)ÀC(23) Segment of
the Diastereomeric Analog of Tedanolide C
€
€
Leila Bulow, Arun Naini, Jorg Fohrer, and Markus Kalesse*
€
Centre for Biomolecular Drug Research, Leibniz Universitat Hannover,
30167 Hannover, Germany
Received September 16, 2011
ABSTRACT
The challenging synthesis of a quaternary center within the highly oxygenated setting of tedanolide C can be performed via a Kiyooka aldol
reaction. Here, the diastereomeric analog of tedanolide C with the configurations between C10 and C20 opposite compared to the proposed
structure was chosen as the synthetic target. The tetra-substituted silyl ketene acetal provides the southern hemisphere of tedanolide C in useful
selectivities, and the absolute configuration of the newly generated quaternary center was determined by NOE experiments of the corresponding
acetonide.
In 2005 Ireland and co-workers isolated tedanolide C (1)
from the marine sponge Ircinia sp.1 It belongs to the
family of the tedanolides which includes, up to now, five
members2À4 which have attracted considerable synthetic
interest.5 Tedanolide C (1) exhibits potent cytotoxicity
against HCT-116 cells in vitro with an IC50 of 57 ng/mL.
Subsequent cell cycle analysis showed that treatment of
HCT-cells with 0.2 μg/mL tedanolide C (1) resulted in a
strong accumulation of cells in the S-phase. These results
indicate that tedanolide C (1) could be a promising lead
compound for the inhibition of protein biosynthesis.6
Tedanolide C (1) contains a highly functionalized 18-
membered macrolactone displaying 12 stereogenic centers
(Figure 1). The side chain, which bears an epoxide, is
characteristic for all members of the tedanolide family.7
(1) Ireland, C. M.; Aalbersberg, W.; Andersen, R. J.; Ayral-Kaloustian,
S.; Berlinck, R.; Bernan, V.; Carter, G.; Churchill, A. C. L.; Clardy, J.;
Concepcion, G. P.; Dilip De Silva, E.; Discafani, C.; Fojo, T.; Frost, P.;
Gibson, D.; Greenberger, L. M.; Greenstein, M.; Harper, M. K.; Mallon,
R.; Loganzo, R.; Nunes, M.; Poruchynsky, M. S.; Zask, A. Pharm Biol.
2003, 41, 15.
(2) Tedanolide: Schmitz, F. J.; Gunasekera, S. P.; Yalamanchili, G.;
Hossain, M. B.; van der Helm, D. J. Am. Chem. Soc. 1984, 106, 7251.
(3) 13-Deoxytedanolide: Fusetani, N.; Sugawara, T.; Matsunaga, S.
J. Org. Chem. 1991, 56, 4971.
(4) Candidaspongiolide: Meragelman, T. L.; Willis, R. H.; Woldemichael,
C. M.; Heaton, A.; Murphy, P. T.; Snader, K. M.; Newman, D. J.; van Soest,
R.; Boyd, M. R.; Cardellina, J. H.; McKee, T. C. J. Am. Prod. 2007, 70, 1133.
(b) Whitson, E. L.; Pluchino, K. M.; Hall, M. D.; McMahon, J. B.; McKee,
T. C. Org. Lett. 2011, 13, 3518.
(5) (a) Smith, A. B.; Adams, C. M.; Barbosa, S. A. L.; Degnan, P.
J. Am. Chem. Soc. 2003, 125, 350. (b) Smith, A. B.; Adams, C. M.;
Barbosa, S. A. L.; Degnan, P. Proc. Natl. Acad. Sci. U.S.A. 2004, 101,
12042. (c) Julian, L. D.; Newcom, J. S.; Roush, W. R. J. Am. Chem. Soc.
2005, 127. (d) Ehrlich, G.; Hassfeld, J.; Eggert, U.; Kalesse, M. J. Am.
Chem. Soc. 2006, 128, 14038. (e) Ehrlich, G.; Hassfeld, J.; Eggert, U.;
Kalesse, M. Chem.;Eur. J. 2008, 14, 2232. (f) Dunetz, J. R.; Julian,
L. D.; Newcom, J. S.; Roush, W. R. J. Am. Chem. Soc. 2008, 130, 16407.
(6) Tedanolide, C; Chevallier, C.; Bugni, T. S.; Feng, X.; Harper,
M. K.; Orendt, A. M.; Ireland, C. M. J. Org. Chem. 2006, 71, 2510.
(7) (a) Taylor, R. E. Nat. Prod. Rep. 2008, 25, 854. (b) Roy, M.;
Kalesse, M. Nat. Prod. Rep. 2008, 25, 862.
r
10.1021/ol202515x
Published on Web 10/25/2011
2011 American Chemical Society